USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES

The present invention relates to novel uses of gamma delta T-cell activating antibodies, in particular uses of such antibodies in patients that are also being treated, or have recently been treated, with aminobisphosphonates, or other inhibitors of the mevalonate pathway that inhibit farnesyl pyroph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RUBEN, Jurjen Matthijs, VAN DER VLIET, Johannes Jelle, ENSING, Erik, PARREN, Paul Willem Henri Ida
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RUBEN, Jurjen Matthijs
VAN DER VLIET, Johannes Jelle
ENSING, Erik
PARREN, Paul Willem Henri Ida
description The present invention relates to novel uses of gamma delta T-cell activating antibodies, in particular uses of such antibodies in patients that are also being treated, or have recently been treated, with aminobisphosphonates, or other inhibitors of the mevalonate pathway that inhibit farnesyl pyrophosphate synthase or an enzyme further downstream in the mevalonate pathway.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4419109A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4419109A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4419109A13</originalsourceid><addsrcrecordid>eNrjZDAIDXYNVvB3U3B39PV1VHBx9QlxVAhRcHb18VFwdA7xDHMM8fRzV3D0C_F08nfxdA3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmJoaWhgaWjobGRCgBALEPJXk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES</title><source>esp@cenet</source><creator>RUBEN, Jurjen Matthijs ; VAN DER VLIET, Johannes Jelle ; ENSING, Erik ; PARREN, Paul Willem Henri Ida</creator><creatorcontrib>RUBEN, Jurjen Matthijs ; VAN DER VLIET, Johannes Jelle ; ENSING, Erik ; PARREN, Paul Willem Henri Ida</creatorcontrib><description>The present invention relates to novel uses of gamma delta T-cell activating antibodies, in particular uses of such antibodies in patients that are also being treated, or have recently been treated, with aminobisphosphonates, or other inhibitors of the mevalonate pathway that inhibit farnesyl pyrophosphate synthase or an enzyme further downstream in the mevalonate pathway.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240828&amp;DB=EPODOC&amp;CC=EP&amp;NR=4419109A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240828&amp;DB=EPODOC&amp;CC=EP&amp;NR=4419109A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RUBEN, Jurjen Matthijs</creatorcontrib><creatorcontrib>VAN DER VLIET, Johannes Jelle</creatorcontrib><creatorcontrib>ENSING, Erik</creatorcontrib><creatorcontrib>PARREN, Paul Willem Henri Ida</creatorcontrib><title>USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES</title><description>The present invention relates to novel uses of gamma delta T-cell activating antibodies, in particular uses of such antibodies in patients that are also being treated, or have recently been treated, with aminobisphosphonates, or other inhibitors of the mevalonate pathway that inhibit farnesyl pyrophosphate synthase or an enzyme further downstream in the mevalonate pathway.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAIDXYNVvB3U3B39PV1VHBx9QlxVAhRcHb18VFwdA7xDHMM8fRzV3D0C_F08nfxdA3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmJoaWhgaWjobGRCgBALEPJXk</recordid><startdate>20240828</startdate><enddate>20240828</enddate><creator>RUBEN, Jurjen Matthijs</creator><creator>VAN DER VLIET, Johannes Jelle</creator><creator>ENSING, Erik</creator><creator>PARREN, Paul Willem Henri Ida</creator><scope>EVB</scope></search><sort><creationdate>20240828</creationdate><title>USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES</title><author>RUBEN, Jurjen Matthijs ; VAN DER VLIET, Johannes Jelle ; ENSING, Erik ; PARREN, Paul Willem Henri Ida</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4419109A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RUBEN, Jurjen Matthijs</creatorcontrib><creatorcontrib>VAN DER VLIET, Johannes Jelle</creatorcontrib><creatorcontrib>ENSING, Erik</creatorcontrib><creatorcontrib>PARREN, Paul Willem Henri Ida</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RUBEN, Jurjen Matthijs</au><au>VAN DER VLIET, Johannes Jelle</au><au>ENSING, Erik</au><au>PARREN, Paul Willem Henri Ida</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES</title><date>2024-08-28</date><risdate>2024</risdate><abstract>The present invention relates to novel uses of gamma delta T-cell activating antibodies, in particular uses of such antibodies in patients that are also being treated, or have recently been treated, with aminobisphosphonates, or other inhibitors of the mevalonate pathway that inhibit farnesyl pyrophosphate synthase or an enzyme further downstream in the mevalonate pathway.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4419109A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USES OF GAMMA DELTA T CELL ACTIVATING ANTIBODIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T05%3A09%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RUBEN,%20Jurjen%20Matthijs&rft.date=2024-08-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4419109A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true